focus -WSS

focus

author：hotspot 2025-09-28 02:32:41 - browse：8418

A sign of Lilly on the top of its biotechnology center — coverage from STAT — Adobe

Eli Lilly reported Thursday that its experimental weekly insulin worked as well as daily basal insulin products in two late-stage studies, paving the way for the drug to compete with a similar weekly insulin developed by Novo Nordisk.

In a 52-week trial of type 2 diabetes patients using insulin for the first time, those on the weekly insulin, called efsitora alfa, had a 1.34% reduction in blood sugar levels, while people on the comparator daily insulin degludec, sold as Tresiba by Novo, had a 1.26% lowering. That resulted in patients having blood sugar levels, known as A1C readings, of 6.87% and 6.95%, respectively.

In a separate 26-week trial of type 2 patients who have been using insulin, those on efsitora and the comparator daily insulin glargine, sold by Lilly as Basaglar and Sanofi as Lantus, both saw A1C reductions of 1.07%, resulting in blood sugar levels of 7.12% and 7.11%, respectively.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： The response to Covid

WSS

Men with early prostate cancer can safely opt out of treatment

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

How a key Senate committee is planning to regulate PBMs

The response to Covid

The UK government moves asylum

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Wildfire smoke exposes gaps in outdoor worker protections

Mississippi candidates for statewide offices square off in party primaries

Drug repurposing or repositioning? The language matters

How a key Senate committee is planning to regulate PBMs

Hollywood unions extend contract negotiations for actors

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Malaria cases in Florida and Texas: Here’s what you need to know

Doctors have an ethical obligation to be advocates

In age of alternative facts, a scholarly course on calling out crap

The response to Covid

focus

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Moderna hits safety problems in bold bid to reinvent medicine

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Why workplace violence is so common in health care

entertainment

Wikipedia

focus

Wikipedia